Literature DB >> 15314272

Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring.

R M Nagler1.   

Abstract

Xerostomia is a major complaint of many elderly individuals, and although they seek medical help, it usually provides no adequate relief. This complaint is considered a major clinical problem, since not less than 25% to 50%-60% of the population over the age of 65 complain of xerostomia. By definition, Xerostomia is a subjective feeling and in up to one-third of the cases does not reflect a real reduction in salivary flow rate but rather the subjective feeling of a dry mouth. Moreover, only a minute portion of the patients suffer from xerostomia with a known aetiology such as radiotherapy or Sjögren's syndrome, while in the majority of the cases, the aetiology is assumed to be related to age, disease, various medications and drugs or is simply idiopathic. The current review focuses on age-related histological, sialometrical and sialochemical changes and on the possible mechanisms which underlie these changes. Finally, directions for further exploring the subject are suggested.

Entities:  

Mesh:

Year:  2004        PMID: 15314272     DOI: 10.1023/B:BGEN.0000038023.36727.50

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  27 in total

Review 1.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice.

Authors:  Toshiharu Hayashi; Hideyuki Hayashi; Taeko Fujii; Chie Adachi; Keiko Hasegawa
Journal:  Virchows Arch       Date:  2008-06-19       Impact factor: 4.064

Review 3.  World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.

Authors:  Alessandro Villa; Andy Wolff; Doron Aframian; Arjan Vissink; Jörgen Ekström; Gordon Proctor; Richard McGowan; Nagamani Narayana; Ardita Aliko; Ying Wai Sia; Revan Kumar Joshi; Siri Beier Jensen; Alexander Ross Kerr; Colin Dawes; Anne Marie Lynge Pedersen
Journal:  Clin Oral Investig       Date:  2015-05-22       Impact factor: 3.573

4.  Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.

Authors:  S Rahman; C M Pierce Campbell; B N Torres; M T O'Keefe; D J Ingles; L L Villa; R J Carvalho da Silva; R C Cintra; E Lazcano-Ponce; J Salmeron; M Quiterio; A R Giuliano
Journal:  Oral Dis       Date:  2016-08-17       Impact factor: 3.511

Review 5.  Symptom identification in the chronically critically ill.

Authors:  Grace B Campbell; Mary Beth Happ
Journal:  AACN Adv Crit Care       Date:  2010 Jan-Mar

6.  Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.

Authors:  Long Meng; Jing Huang; Qin He; Yibei Zhao; Wenlong Zhao; Juntao Tan; Shusen Sun; Junqing Yang
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

Review 7.  Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.

Authors:  Anna Greta Barbe
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

8.  Age and gender characteristics of the biochemical composition of saliva: Correlations with the composition of blood plasma.

Authors:  Lyudmila V Bel'skaya; Elena A Sarf; Victor K Kosenok
Journal:  J Oral Biol Craniofac Res       Date:  2020-02-14

9.  Salivary pH as a marker of plasma adiponectin concentrations in Women.

Authors:  Monique Tremblay; Yacine Loucif; Julie Methot; Diane Brisson; Daniel Gaudet
Journal:  Diabetol Metab Syndr       Date:  2012-02-03       Impact factor: 3.320

Review 10.  Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.

Authors:  Fernando Bartolomé; Luigi Rosa; Piera Valenti; Francisco Lopera; Jesús Hernández-Gallego; José Luis Cantero; Gorka Orive; Eva Carro
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.